TP53 and non-small cell lung carcinoma: In contrast to human non-small cell lung cancer cell lines35, cell lines derived from the KrasG12D-driven p53-deficient mouse lung adenocarcinoma model38, and the mouse breast cancer cell line 4T148, Hmga2 knockdown in murine PDAC cells did not reduce metastatic ability in vivo.